StopDown
4baseCare logo
Company

4baseCare

Genomics-driven cancer diagnostics4basecare.com ↗LinkedIn ↗Instagram ↗

4baseCare revenue, valuation and funding

It has raised Rs 128 Cr in total, as reported by StopDown on 11 June 2026.

4baseCare revenue, valuation and funding
Total raisedRs 128 Cr

Each figure links to the story that reported it.

4baseCare key facts

₹128 croreSeries B totalJun 2026 Profile

Funding rounds

4baseCare funding rounds, as announced
WhenRoundAmountInvestorsSource
2024Series A₹50 croreYali Capital (lead) Express Healthcare
Jan 2026Series B, first close₹90 croreAshish Kacholia (co-lead), Lashit Sanghvi (co-lead), Yali Capital EntrackrExpress Healthcare
Jun 2026Series B, top-up₹38 croregrowX Ventures, Infosys, existing investors Entrackr

Timeline

  • 2019
  • 2019 Hitesh Goswami and Kshitij Rishi found 4baseCare Entrackr
  • 2024
  • 2024 Series A of about ₹50 crore, led by Yali Capital Express Healthcare
  • 2026
  • Jan 2026 First close of Series B: ₹90 crore, co-led by Ashish Kacholia and Lashit Sanghvi EntrackrExpress Healthcare
  • Jun 2026 ₹38 crore top-up takes the Series B to ₹128 crore Entrackr

The short version

  • 4baseCare is a precision oncology company that links genomic cancer tests with clinical data to guide treatment. Express HealthcareEntrackr
  • Hitesh Goswami and Kshitij Rishi founded it in 2019; Goswami is the CEO. EntrackrExpress Healthcare
  • In January 2026 it announced the first close of its Series B: ₹90 crore, co-led by Ashish Kacholia and Lashit Sanghvi, with existing investor Yali Capital taking part. EntrackrExpress Healthcare
  • In June 2026 it added a ₹38 crore top-up to reach ₹128 crore for the Series B. Entrackr names growX Ventures and Infosys among the new money. Entrackr
  • The money is for a network of hospital-linked genomics labs across India and overseas and for AI tools such as OncoTwin Insights that help doctors read treatment data. Express Healthcare
  • Its Series A was about ₹50 crore in 2024, led by Yali Capital. Express Healthcare

Products

  • OncoTwin: A platform that turns genomic and clinical data into treatment insights for oncologists. It was picked for the MSK iHub programme of Memorial Sloan Kettering in New York. Express Healthcare

People

Questions people ask about 4baseCare

How much has 4baseCare raised?

4baseCare raised ₹128 crore (about $13.3 million) in its Series B by June 2026: ₹90 crore in the first close in January and a ₹38 crore top-up. It had earlier raised about ₹50 crore in a Series A in 2024, led by Yali Capital. EntrackrExpress Healthcare

Who founded 4baseCare?

Hitesh Goswami and Kshitij Rishi founded 4baseCare in 2019. Goswami is the chief executive. The company sells precision oncology services that join genomic testing with clinical data. EntrackrExpress Healthcare

Who invested in 4baseCare?

In the Series B, Ashish Kacholia and Lashit Sanghvi co-led the ₹90 crore first close in January 2026, with Yali Capital. The June 2026 top-up added growX Ventures and Infosys. Yali Capital led the ₹50 crore Series A in 2024. EntrackrEntrackrExpress Healthcare

What is 4baseCare's valuation?

No valuation for 4baseCare has been disclosed in the reports on its Series B. The company has not published a revenue or profit figure for a full financial year either, so no financial year numbers are listed here. Entrackr

Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-14.

Stories cover its funding and roundup news. Sectors: Healthcare & Life Sciences. Stages: Series-b. Stories run from 27 January 2026 to 11 June 2026.

The founders

Hitesh Goswami

Co-founder and CEO

Kshitij Rishi

Co-founder

Who put in money

Yali CapitalAshish KacholiaAshish Kacholia (Lucky Investment Managers)growX VenturesInfosysLashit Sanghvi

Every story on 4baseCare

For 4baseCare: add the “Featured on StopDown” badge

Put this on your website's press or media page. It links readers to 4baseCare on StopDown.

Featured on StopDownFeatured on StopDown, dark

· About the badge